【レポートの概要（一部）】
1. Analyst View
2. Research Methodology
3. Global Protein Therapeutics Market
3.1 Protein Therapeutics Market vs Pharmaceutical Market
3.2 Current and Future Market Analysis to 2020
3.2.1 Market Segmentation
3.2.2 Market Dynamics
3.2.2.1 Drivers
3.2.2.1.1 Increasing Healthcare Expenditure in the Emerging Markets
3.2.2.1.2 Government Initiatives to Improve the Healthcare Services
3.2.2.1.3 Rising Prevalence of Chronic Diseases
3.2.2.1.4 Growing Geriatric Population
3.2.2.2 Challenges
3.2.2.2.1 High Cost of Production and Treatment
3.2.2.2.2 Competition from Biosimilars
3.2.2.2.3 Patent Expiry of Blockbuster Drugs
3.2.2.3 Opportunities
3.2.2.3.1 Potential for Bispecific Monoclonal Antibodies
3.2.2.3.2 Unmet Medical Needs in the Developing Countries
4. Industry Performance
4.1 Monoclonal Antibodies (mAbs)
4.1.1 Scientific Insight
4.1.2 Current and Future Market Analysis to 2020
4.1.3 By Application
4.1.4 Key Geographical Markets
4.1.5 Key Players and Drugs
4.1.6 Recent Developments
4.2 Erythropoietin (EPO)
4.2.1 Scientific Insight
4.2.2 Current and Future Market Analysis to 2020
4.2.3 By Application
4.2.4 Key Geographical Markets
4.2.5 Key Players and Drugs
4.2.6 Recent Developments
4.3 Insulin
4.3.1 Scientific Insight
4.3.2 Current and Future Market Analysis to 2020
4.3.3 By Application
4.3.4 Key Geographical Markets
4.3.5 Key Players and Drugs
4.3.6 Recent Developments
4.4 Interferon (IFN)
4.4.1 Scientific Insight
4.4.2 Current and Future Market Analysis to 2020
4.4.3 By Application
4.4.4 Key Geographical Markets
4.4.5 Key Players and Drugs
4.4.6 Recent Developments
4.5 Human Growth Hormone (HGH)
4.5.1 Scientific Insight
4.5.2 Current and Future Market Analysis to 2020
4.5.3 Key Geographical Markets
4.5.4 Key Players and Drugs
4.5.5 Recent Developments
4.6 Blood Clotting Factor
4.6.1 Scientific Insight
4.6.2 Current and Future Market Analysis to 2020
4.6.3 By Factor Type
4.6.4 Key Geographical Markets
4.6.5 Key Players and Drugs
4.6.6 Recent Developments
4.7 Follicle Stimulating Hormone (FSH)
4.7.1 Scientific Insight
4.7.2 Current and Future Market Analysis to 2020
4.7.3 Key Players and Drugs
4.7.4 Recent Developments
4.8 Granulocyte Colony Stimulating Factor (G-CSF)
4.8.1 Scientific Insight
4.8.2 Current and Future Market Analysis to 2020
4.8.3 Key Geographical Markets
4.8.4 Key Players and Drugs
4.8.5 Recent Developments
5. Advanced Phase Drugs Analysis
6. Emerging Market Trends
6.1 Gaining Momentum: Strategic Activities among Players to Develop Novel Treatments
6.2 Effective Delivery Methods: Improving the Reach of Therapies
6.3 Players Investing Heavily in Multiple Sclerosis and Cancer Therapeutics
6.4 Increasing Focus on Development of Biobetters
7. Porters Five Forces Analysis
8. Key Players
8.1 Johnson & Johnson
8.2 Biogen Idec Inc.
8.3 Eli Lilly & Company
8.4 Sanofi-Aventis
8.5 Merck Serono S.A.
8.6 Roche Group
8.7 Amgen Inc.
8.8 Pfizer
8.9 Abbott Laboratories
8.10 Novo Nordisk
List of Figures:
Figure 3-1: Global – Protein Therapeutics vs Pharmaceutical Market (Billion US$), 2014
Figure 3-2: Global – Protein Therapeutics Market (Billion US$), 2013-2020
Figure 3-3: Global – Protein Therapeutics Market by Segment (%), 2014
Figure 3-4: Global – Forecast for Protein Therapeutics Market by Segment (%), 2020
Figure 4-1: Global – Monoclonal Antibodies Market (Billion US$), 2013-2020
Figure 4-2: Global – Monoclonal Antibodies Market by Application (%), 2014
Figure 4-3: Global – Monoclonal Antibodies Application in Cancer Treatment (Billion US$), 2013-2020
Figure 4-4: Global – Monoclonal Antibodies Application in Rheumatoid Arthritis Treatment (Billion US$), 2013-2020
Figure 4-5: Global – Monoclonal Antibodies Application in Other Chronic Diseases Treatment (Billion US$), 2013-2020
Figure 4-6: US – Monoclonal Antibodies Market (Billion US$), 2013-2020
Figure 4-7: Europe – Monoclonal Antibodies Market (Billion US$), 2013-2020
Figure 4-8: Japan – Monoclonal Antibodies Market (Billion US$), 2013-2020
Figure 4-9: Global – Monoclonal Antibody Market by Key Players (%) (2014)
Figure 4-10: Global – Erythropoietin Market (Billion US$), 2012-2018
Figure 4-11: Global – Erythropoietin Market by Segment (%) (2014)
Figure 4-12: Global – Number of Patients on Dialysis (Million), 2014 & 2020
Figure 4-13: Global – Breakup of Patients on Dialysis by Region (%), 2014
Figure 4-14: Global – Number of New Cancer Cases (Million), 2012 & 2020
Figure 4-15: Global – Breakup of New Cancer Cases by Region (%), 2020
Figure 4-16: US – Erythropoietin Market (Billion US$), 2013-2020
Figure 4-17: Europe – Erythropoietin Market (Billion US$), 2013-2020
Figure 4-18: Global – Erythropoietin Market by Key Player (%), (2014)
Figure 4-19: Global – Insulin Market (Billion US$), 2013-2020
Figure 4-20: Global – Number of Diabetic Patients (Million), 2013 & 2035
Figure 4-21: US – Insulin Market (Billion US$), 2013-2020
Figure 4-22: Europe – Insulin Market (Billion US$), 2013-2020
Figure 4-23: Asia – Insulin Market (Billion US$), 2013-2020
Figure 4-24: Global – Insulin Market by Key Players (%) (2014)
Figure 4-25: Global – Insulin Market by Products (%)(2014)
Figure 4-26: Global – Interferon Market (Billion US$), 2013-2020
Figure 4-27: Global – Interferon Market by Segment (%) (2014)
Figure 4-28: Global – Interferon Alpha Market (Billion US$), 2012-2014
Figure 4-29: Global – Interferon Beta Market (Billion US$), 2012-2014
Figure 4-30: US – Interferon Market (Billion US$), 2013-2020
Figure 4-31: Europe – Interferon Market (Billion US$), 2013-2020
Figure 4-32: Global – Interferon Market by Key Player (%) (2014)
Figure 4-33: Global – Human Growth Hormone Market (Billion US$), 2013-2020
Figure 4-34: US – Human Growth Hormone Market (Billion US$), 2013-2020
Figure 4-35: Europe – Human Growth Hormone Market (Billion US$), 2013-2020
Figure 4-36: Global – Human Growth Hormone Market by Key Players (%) (2014)
Figure 4-37: Global – Blood Clotting Factor Market (Billion US$), 2013-2020
Figure 4-38: Global – Blood Clotting Factor Market by Segment (%) (2014)
Figure 4-39: Global – Blood Clotting Recombinant Factor VIII Market (Billion US$), 2013-2020
Figure 4-40: Global – Recombinant Blood Clotting Factor VII Market (Billion US$), 2013-2020
Figure 4-41: Global – Recombinant Blood Clotting Factor Market IX (Billion US$), 2013-2020
Figure 4-42: US – Blood Clotting Factor Market (Billion US$), 2013-2020
Figure 4-43: Europe – Blood Clotting Factor Market (Billion US$), 2013-2020
Figure 4-44: Global – Blood Clotting Factor Market by Key Players (%) (2014)
Figure 4-45: Global – Follicle Stimulating Hormone Market (Billion US$), 2013-2020
Figure 4-46: Global – Granulocyte Colony Stimulating Factor Market (Billion US$), 2013-2020
Figure 4-47: US – Granulocyte Colony-Stimulating Factor Market (Billion US$), 2013-2020
Figure 4-48: Europe – Granulocyte Colony-Stimulating Factor Market (Billion US$), 2013-2020
Figure 7-1: Porters Five Forces Analysis
List of Tables:
Table 3-1: US & Europe – Major Drugs Patent Expiry in Protein Therapeutics Market
Table 4-1: Global – Key Players and Drugs in Monoclonal Antibody Market (Billion US$), 2012-2014
Table 4-2: Global – Key Players and Drugs in Erythropoietin Alfa Market (Billion US$), 2012-2014
Table 4-3: Global – Key Players and Drugs in Erythropoietin Beta Market (Billion US$), 2012-2014
Table 4-4: Global – Key Players and Drugs in Darbepoetin Market (Billion US$), 2012-2014
Table 4-5: US – Diabetic Patients in Age Group 20-79 Years (‘000), 2013 & 2035f
Table 4-6: Europe – Diabetic Patients in Age Group 20-79 Years (‘000), 2013 & 2035
Table 4-7: China – Diabetic Patients in Age Group 20-79 Years (‘000), 2013 & 2035f
Table 4-8: Global – Key Players and Drugs in Interferon Alpha Market (Billion US$), 2012-2014
Table 4-9: Global – Key Players and Drugs in Interferon Beta Market (Billion US$), 2012-2014
Table 4-10: Global – Key Players and Drugs in Human Growth Hormone Market (Billion US$), 2012-2014
Table 4-11: Global – Key Players and Drugs in Blood Clotting Factor Market (Billion US$), 2012-2014
Table 4-12: Global – Key Players and Drugs in Follicle Stimulating Hormone Market (Billion US$), 2012-2014
Table 4-13: Global – Key Players and Drugs in Granulocyte Colony Stimulating Factor Market (Billion US$), 2012-2014
Table 5-1: Advanced Phase Protein Therapeutics
Table 8-1: Johnson & Johnson – Key Products in Protein Therapeutics
Table 8-2: Biogen – Key Products in Protein Therapeutics
Table 8-3: Eli Lilly – Key Products in Protein Therapeutics
Table 8-4: Sanofi-Aventis – Key Products in Protein Therapeutics
Table 8-5: Merck Serono – Key Products in Protein Therapeutics
Table 8-6: Roche – Key Products in Protein Therapeutics
Table 8-7: Amgen Inc. – Key Products in Protein Therapeutics
Table 8-8: Pfizer Inc. – Key Products in Protein Therapeutics
Table 8-9: Abbott Laboratories – Key Products in Protein Therapeutics
Table 8-10: Novo Nordisk – Key Products in Protein Therapeutics
【レポート販売概要】
■ タイトル：世界のタンパク質治療薬市場■ 英文：Global Protein Therapeutics Market Outlook 2020
■ 発行日：2015年9月
■ 調査会社：RNCOS
■ 商品コード：RNCOS50908
■ 調査対象地域：グローバル
- 合成ガス及び誘導体の世界市場Syngas is primarily used for the production of chemical derivatives, such as ammonia, methanol, hydrogen, and oxo chemicals. These derivatives are further used for the production of several other derivatives; for example, ammonia for urea and others, and methanol for formaldehyde and others. The global demand for ammonium fertilizers is anticipated to grow at a CAGR of 2.7% between 2015 and 2020. …
- 2014年戦略提言：イギリスの治療薬物モニタリング(TDM)市場This new 247-page report from Venture Planning Group provides a comprehensive analysis of the UK therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamaze …
- デセプション技術の世界市場2016-2020About Cyber Deception The term cyber deception was coined in 1989 by Gene Spafford. He sourced active defenses to identify attacks in the network, slow down attackers while they attempt to infuse virus attacks, learn their techniques, and feed them with fake data. In 1999, the Honeynet Project was launched, with innovation to the deception techniques and ways to understand and learn the behavior a …
- サーモン缶詰の世界市場2016-2020About Salmon Salmon is the common name for fishes belonging to the family of Salmonidae. It is available from both wild and farmed sources. It is estimated that nearly 60% of the world's salmon production is farmed. Salmon farming started in the beginning of 1960s. Atlantic salmon is the most common type of salmon that is farmed. Major part of Atlantic salmon available around the globe are farmed …
- 断熱ガラスの世界市場分析：用途別（非住宅建設、住宅建設、工業）、地域別（北アメリカ、ヨーロッパ、アジア太平洋、中南米、中東、アフリカ）、セグメント予測、2014-2025The global insulating glass market is expected to reach USD 4.26 billion by 2025, according to a new report by Grand View Research, Inc. The rising awareness about energy efficient buildings is expected to drive demand for insulating glass. Insulating glass is a special type of value added product which is installed to keep the environment warmer in winters and cooler during the summer season. The …
- Venoco, Inc.：石油・ガスの開発・生産動向及びコスト分析– Q1, 2013Venoco, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis – Q1, 2013 Summary Venoco, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key operation …
- 自己免疫疾患診断の世界市場の規模および予測：タイプ別（全身性自己免疫疾患診断、局所自己免疫疾患診断）、地域別、動向の分析 2014-2025The global autoimmune disease diagnostics market is expected to reach a value of USD 5.0 billion by 2025, based on a new report by Grand View Research, Inc. Government organizations along with related associations strive to curb such high healthcare costs and simultaneously provide improved diagnostic and therapeutic solutions to the patients. This has resulted in increased funding by the NIH for …
- アセトンの世界市場2016-2020About Acetone Acetone is produced as co-product in cumene peroxidation process for phenol production. It can also be commercially produced by the dehydrogenation of 2-propanol or isopropyl alcohol. The compound has a sweet odor and is highly inflammable. It is popularly used as a solvent in many industries. It is also used as an intermediate in manufacturing other complex chemicals. Technavio’s an …
- 高等教育向けクラウド式コンテンツ管理サービスの世界市場2016-2020About Cloud Computing Cloud computing is being increasingly adopted by educational institutions as it offers flexible and scalable services at nominal costs, such as consumption-based payment models. These exempt educational institutions from investments in outdated hardware and applications and enable them to adapt the latest technologies. In addition, apart from providing numerous client platfor …
- エクスフォリエーターおよびスクラブの世界市場2016-2020About Exfoliators and Scrubs Vendors operating in the global exfoliators and scrubs market are introducing various sales offers, such as discounts and bundle offers, for consumers to trigger sales. These offers also act as marketing and promotional tactics. Although brick-and-mortar retailing remains the key channel for the sales of exfoliators and scrubs, Internet retailing will see fast growth o …
- グローバルスマートフォン市場動向Product Synopsis Emerging Markets Will Generate 58% of Smartphone Sales in 2012-2017 Smartphone Research in Focus Q2 2013 More than half of the world's smartphones were sold in emerging markets in 2012. Globally, smartphone unit sales grew at a CAGR of 52.7% between 2008 and 2012, reaching 641m. Looking forward, smartphone sell-through will increase at a CAGR of 18.3% through 2017, reaching 1.5bn …
- 世界の自己免疫疾患用装置開発動向：医療機器パイプライン分析2015Auto-Immune Diseases - Medical Devices Pipeline Assessment, 2015 Summary GlobalData's Medical Devices sector report, “Auto-Immune Diseases - Medical Devices Pipeline Assessment, 2015" provides an overview of Auto-Immune Diseases currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of developm …
- Bill Barrett Corporation社の石油・ガス開発・生産動向及びコスト分析（2013年第4四半期）Bill Barrett Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2013 Summary Bill Barrett Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential …
- PTFEファブリックの世界市場：タイプ別（PTFE被覆ファブリック、不織布、PTFE繊維からなるファブリック）、最終用途産業別（食品、建設、ろ過、その他）、地域別予測Global PTFE Fabric Market to reach USD 1028.8 million by 2025. Global PTFE Fabric Market valued approximately USD 630 million in 2016 is anticipated to grow with a healthy growth rate of more than 5.60% over the forecast period 2017-2025. High demand for PTFE fabrics in the automotive industry, their growing consumption in the construction industry, and increasing consumption of composite fabrics …
- 世界のホームエンターテインメント装置（機械）市場動向（2012-2016）TechNavio's analysts forecast the Global Home Entertainment Equipment market to grow at a CAGR of 2.50 percent over the period 2012-2016. One of the key factors contributing to this market growth is the growing urbanization in developing countries. The Global Home Entertainment Equipment market has also been witnessing the development of technologically advanced home entertainment devices. However …
